MACQUARIE GROUP LTD 13D and 13G filings for Adamas Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-12 08:23 am Sale | 2020-12-31 | 13G | Adamas Pharmaceuticals, Inc. ADMS | MACQUARIE GROUP LTD | 0 0.000% | -2,167,416![]() (Position Closed) | Filing |